The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease—A cross sectional study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Leech, 1990, Relationship of lung function to severity of osteoporosis in women, Am Rev Respir Dis, 141, 68, 10.1164/ajrccm/141.1.68
Walsh, 2001, Adverse effects of oral corticosteroids in relation to dose in patients with lung disease, Thorax, 56, 279, 10.1136/thorax.56.4.279
Goldstein, 1999, Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease, Chest, 116, 1733, 10.1378/chest.116.6.1733
Singh, 2002, Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review, Arch Intern Med, 162, 2527, 10.1001/archinte.162.22.2527
Ledford, 1998, Osteoporosis in the corticosteroid-treated patient with asthma, J Allergy Clin Immunol, 102, 353, 10.1016/S0091-6749(98)70120-4
Gluck, 2004, Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases, Chest, 125, 1859, 10.1378/chest.125.5.1859
McEvoy, 1998, Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 157, 704, 10.1164/ajrccm.157.3.9703080
Kanis, 2004, A meta-analysis of prior corticosteroid use and fracture risk, J Bone Miner Res, 19, 893, 10.1359/JBMR.040134
2000, Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease, N Engl J Med, 343, 1902, 10.1056/NEJM200012283432601
Burge, 2000, Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial, Br Med J, 320, 1297, 10.1136/bmj.320.7245.1297
Jarad, 1999, An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group, Respir Med, 93, 161, 10.1016/S0954-6111(99)90001-X
Vestbo, 1999, Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial, Lancet, 353, 1819, 10.1016/S0140-6736(98)10019-3
Praet, 1992, Risk of osteoporosis in men with chronic bronchitis, Osteoporos Int, 2, 257, 10.1007/BF01624152
Iqbal, 1999, Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function, Chest, 116, 1616, 10.1378/chest.116.6.1616
Vestbo, 2006, Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study, Am J Respir Crit Care Med, 173, 79
Cherniack, 1992
Ip, 1994, Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids, Chest, 105, 1722, 10.1378/chest.105.6.1722
Ziegler, 1998, Glucocorticoid-induced osteoporosis: prevention and treatment, Steroids, 63, 344, 10.1016/S0039-128X(98)00022-1
Shane, 1996, Osteoporosis in lung transplantation candidates with end-stage pulmonary disease, Am J Med, 101, 262, 10.1016/S0002-9343(96)00155-6
Reid, 1987, Corticosteroids and bone mass in asthma, Br Med J (Clin Res Ed), 294, 1416, 10.1136/bmj.294.6584.1416
Packe, 1992, Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids, Thorax, 47, 414, 10.1136/thx.47.6.414
Boulet, 1994, Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism, J Allergy Clin Immunol, 94, 796, 10.1016/0091-6749(94)90145-7
Baraldi, 1994, Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic children: a longitudinal evaluation, Eur Respir J, 7, 710, 10.1183/09031936.94.07040710